The biopharmaceutical firm Incyte Corp. has signed a 15 year lease to occupy a former department store building in Wilmington.
WATCH: Famous Rabbi, Daughter Recount Mall Shooting Scare
The company has for years rented space at the DuPont Experimental Station in Wilmington.
Incyte's CEO Paul A. Friedman says the company's 372 Delaware employees are looking forward to moving into their new home, the former John Wanamaker building, by the end of next year.
Incyte opened its first labs in Delaware 10 years ago and has since developed the first drug approved by the Food and Drug Administration to treat a rare blood cancer, myelofibrosis.
The drug is called Jakafi.